MYLAN 2045 MYLAN 2045 Pill: orange gray, capsule/oblong, 14mm
The pill with imprint MYLAN 2045 MYLAN 2045 (Orange / Gray, Capsule/Oblong, 14mm) has been identified as Tacrolimus 0.5 mg and is used for Organ Transplant, Rejection Prophylaxis, and Organ Transplant, Rejection Reversal. It belongs to the drug class calcineurin inhibitors and is not a controlled substance.
Images for MYLAN 2045 MYLAN 2045
Tacrolimus
- Imprint
- MYLAN 2045 MYLAN 2045
- Strength
- 0.5 mg
- Color
- Orange / Gray
- Size
- 14.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Calcineurin inhibitors
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
- Inactive Ingredients
-
lactose anhydrous,
ferrosoferric oxide,
silicon dioxide,
croscarmellose sodium,
gelatin,
hypromelloses,
lactose monohydrate,
magnesium stearate,
sodium lauryl sulfate,
titanium dioxide,
ferric oxide yellow,
D&C Red No. 28,
D&C Yellow No. 10,
FD&C Red No. 40,
FD&C Blue No. 1,
FD&C Blue No. 2,
propylene glycol,
shellac
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00378-2045 | Mylan Pharmaceuticals Inc. |
| 51079-0817 | UDL Laboratories Inc. |
See also:
More about tacrolimus
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (50)
- Drug images
- Latest FDA alerts (3)
- Side effects
- Dosage information
- During pregnancy
- Drug class: calcineurin inhibitors
- Breastfeeding
- En español
Patient resources
- Tacrolimus oral and injection drug information
- Tacrolimus (Intravenous) (Advanced Reading)
- Tacrolimus (Oral) (Advanced Reading)
- Tacrolimus Capsules
- Tacrolimus Extended-Release Tablets
Other brands
Prograf, Envarsus XR, Astagraf XL, Hecoria
Professional resources
Other brands
Prograf, Envarsus XR, Astagraf XL
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.